In this study, we demonstrated that the levels of CCL11 in serum from RA patients were higher than those in the serum from HC, and the levels of CCL11 in SFs from patients with RA were higher than those in SFs from patients with OA. The gene discussed is CCL11; the disease is rheumatoid arthritis.